Plain-English translation of NCT06504732 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This is a two-phase study testing a new drug called to see if it works better when combined with chemotherapy (called CAPEOX) for treating advanced stomach cancer and other solid tumors. The study will compare the new medication to an existing standard treatment, measuring how well it shrinks tumors and how safe it is.
Many patients with advanced stomach cancer need better treatment options that work more effectively and with fewer side effects. This study is exploring whether this new medication could be a more effective choice, especially when combined with existing chemotherapy.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic regularly to receive the medication by infusion and chemotherapy pills, with blood work and imaging scans every 6 weeks to track how your tumors respond. The study continues until your disease progresses, you start a new cancer treatment, or side effects become too difficult to manage. After treatment ends, you'll have follow-up telephone calls every 12 weeks to check on your health and survival.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
China